Related Experiment Videos
What can we learn about dense low density lipoprotein and lipoprotein particles from clinical trials?
1Berkeley Heart Lab, Cholesterol, Genetics and Heart Disease Institute, San Mateo, CA 94402, USA.
Insights
Small LDL particle pattern B and triglyceride-rich lipoproteins are key coronary heart disease risk factors. Patients with these traits benefit most from lipid-lowering treatments, showing improved arteriographic responses.
Area of Science:
- Cardiology
- Lipidology
- Preventive Medicine
Background:
- Small LDL particle pattern B and triglyceride-rich lipoproteins are established coronary heart disease (CHD) risk factors.
- These lipid abnormalities are linked to increased CHD severity.
Purpose of the Study:
- To highlight the significance of small LDL particle pattern B and triglyceride-rich lipoproteins in cardiovascular risk stratification.
- To emphasize the unique therapeutic response observed in patients with these lipid profiles.
Main Methods:
- Review of established literature on LDL subclass patterns and cardiovascular risk.
- Analysis of clinical trial data demonstrating differential treatment responses based on LDL subclass pattern.
Main Results:
- Patients with small LDL particle pattern B and triglyceride-rich lipoproteins represent a high-risk subgroup for coronary artery disease (CAD).
- This subgroup exhibits the most favorable arteriographic response to lipid-lowering therapies.
- Lipid-lowering treatments show differential effects in pattern A versus pattern B LDL subclasses, explaining observed clinical outcomes.
Conclusions:
- Small LDL particle pattern B and triglyceride-rich lipoproteins are critical indicators of substantial CAD risk.
- Identifying patients with these patterns allows for targeted therapeutic strategies with optimal arteriographic benefits.
Abstract:
The small LDL pattern B trait, and triglyceride rich lipoproteins, have now been established as major coronary heart disease risk factors and have been associated with its severity. The presence of these disorders identifies a patient subgroup which is at substantial coronary artery disease risk but also exhibits the best arteriographic response to treatment. Most lipid-lowering treatments have a differential effect in LDL subclass pattern A patients compared with those with pattern B that helps explain the differential arteriographic response seen in clinical trials.